Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation THT 2025

reBEAT: Biventricular Epicardial Augmentation Technology for HF Patients: Introducing a Novel MCS Technology, First-in-Human Translational Insights, Strategy for Pivotal Trial and Market Entry

Presenter: Stephen Wildhirt

February 13, 2025

Presentation THT 2025

Role of MCS in PE Management

Presenter: Karthikeyan Ranganathan

February 12, 2025

Presentation THT 2025

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Presenter: Emily Rodriguez

February 11, 2025

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presenter: Candice Lee

March 06, 2024

Presentation THT 2024

Continue MCS for Another 14 days

Presenter: Manreet Kanwar

March 04, 2024

Presentation THT 2024

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Presenter: Shmuel Chen

March 04, 2024

Presentation THT 2023

Acute MR With MCS/TEER

Presenter: Thomas Waggoner

March 21, 2023

Presentation THT 2023

Cardiogenic Shock With MCS and Review of Shock Algorithm

Presenter: Raymond Yau

March 21, 2023

Presentation THT 2023

Assessing RV Function in Cardiogenic Shock: When to Pull the Trigger on MCS

Presenter: Arthur Reshad Garan

March 21, 2023

Presentation THT 2023

Role of Temporary MCS in Pulmonary Arterial Hypertension

Presenter: Eduardo Rame

March 21, 2023

Presentation THT 2023

Novel applications for counterpulsation

Presenter: Ran Lee

March 21, 2023

Presentation THT 2023

Predictors for a positive hemodynamic & clinical response to intra-aortic counterpulsation

Presenter: A. Reshad Garan

March 21, 2023

Presentation THT 2023

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

Presenter: Rachna Kataria

March 21, 2023

Presentation THT 2023

Principles and unique physiological effects characteristic of counterpulsation

Presenter: Arvind Bhimaraj

March 21, 2023

Presentation THT 2023

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Presenter: Jonathan Menachem

March 20, 2023

Advertisement

reBEAT: Biventricular Epicardial Augmentation Technology for HF Patients: Introducing a Novel MCS Technology, First-in-Human Translational Insights, Strategy for Pivotal Trial and Market Entry

Role of MCS in PE Management

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Continue MCS for Another 14 days

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Acute MR With MCS/TEER

Cardiogenic Shock With MCS and Review of Shock Algorithm

Assessing RV Function in Cardiogenic Shock: When to Pull the Trigger on MCS

Role of Temporary MCS in Pulmonary Arterial Hypertension

Novel applications for counterpulsation

Predictors for a positive hemodynamic & clinical response to intra-aortic counterpulsation

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

Principles and unique physiological effects characteristic of counterpulsation

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content